NCT05789394 2026-04-02
Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy
Mayo Clinic
Phase 1 Recruiting
Mayo Clinic
Case Comprehensive Cancer Center
Thomas Jefferson University
University of Aarhus
Ohio State University Comprehensive Cancer Center
Tampa General Hospital